Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases

R. ter Heine, R. Lange, O.B. Breukels, H.J. Bloemendal, R.G. Rummenie, A.M. Wakker, H. de Graaf, F.J. Beekman, M.M.L. van der Westerlaken, M.M. Malingre, J.P.M. Wielders, L. van den Berg, N.H. Hendrikse, J.M.H. de Klerk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)317-324
JournalInternational journal of pharmaceutics
Volume465
Issue number1-2
DOIs
Publication statusPublished - 2014

Cite this

ter Heine, R., Lange, R., Breukels, O. B., Bloemendal, H. J., Rummenie, R. G., Wakker, A. M., ... de Klerk, J. M. H. (2014). Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases. International journal of pharmaceutics, 465(1-2), 317-324. https://doi.org/10.1016/j.ijpharm.2014.01.034